The content on this website is intended solely for veterinarians and other animal health professionals.
By using this website, you confirm that the above applies to you.
Intervacc has presented results from clinical trials at WEAS 2017
The WEAS (World Equine Airway Symposium) is a regularly recurring international scientific meeting on diseases of the horse’s airways. At WEAS 2017 in Copenhagen in July 2017, Intervacc CEO Jan-Ingmar Flock presented data from the clinical trials conducted with...Intervacc now on Introduce.se
Starting today March 1st, 2017 Intervacc becomes overviewed by Introduce.se Intervacc is now presented on introduce.se, a Swedish language website designed to provide overviews of publicly traded companies and to provide independent investor information. The...Intervacc signs agreement for optimization of manufacturing
Intervacc is pleased to announce that an agreement has now been signed with PX´Therapeutics, Grenoble, France, for process optimization of Strangvac. PX´Therapeutics, a subsidiary of Aguettant pharmaceutical group, has the experience, facilities and personnel to...Animal Pharm writes about strangles and Strangvac®
The recognized journal Animal Pharm once again highlights Strangvac® in an article about the research now approaching a solution regarding effective vaccine protection against strangles. The article points out that, despite over 100 years of research the disease...Nyhetstjänster
